Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17182297 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed EVA: Evista Alendronate Comparison
Condition: Osteoporosis
Intervention: Drug: raloxifene HCI and alendronate Na

Study has passed its completion date and status has not been verified in more than two years.